A Voloch

Class III β-tubulin expression in tumor cells predicts response and outcome in patients with non–small cell lung cancer receiving paclitaxel

P. Sève, John R. Mackey, Sylvie Isaac et al. · Molecular Cancer Therapeutics · 2005 · 219 citations

Medicine, Oncology, Pharmacology +17

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 128 citations

Medicine, Oncology, Breast Oncology +9

A controlled ‘before-after’ study: impact of a clinical guidelines programme and regional cancer network organization on medical practice

Isabelle Ray‐Coquard, Thierry Philip, Guy de Laroche et al. · British Journal of Cancer · 2002 · 102 citations · Full text

Medicine, Oncology, Breast Oncology +6

Persistence of Medical Change at Implementation of Clinical Guidelines on Medical Practice: A Controlled Study in a Cancer Network

Isabelle Ray‐Coquard, Thierry Philip, Guy de Laroche et al. · Journal of Clinical Oncology · 2005 · 64 citations · Full text

Law, Oncology, Cancer Control +13

Whole-Body MRI for Metastases Screening: A Preliminary Study Using 3D VIBE Sequences With Automatic Subtraction Between Noncontrast and Contrast Enhanced Images

Vivien Thomson, Jean‐Baptiste Pialat, Frédéric Gay et al. · American Journal of Clinical Oncology · 2008 · 40 citations

Medicine, Oncology, Radiology +17